Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,785
datasets available to search
ShareScore release 0.9.0
Dataset results
2,785 results for “genotyping”
A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV)
ClinicalTrials.gov study NCT00627926. IPD Sharing: Not stated. Countries: 13. Publications: 1.
A Study of TMC435 in Combination With Pegylated Interferon Alp\Fa-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment
ClinicalTrials.gov study NCT00882908. IPD Sharing: Not stated. Countries: 13. Publications: 3.
Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected Subjects
ClinicalTrials.gov study NCT01314261. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Efficacy and Safety of Elbasvir (MK-8742) + Grazoprevir (MK-5172) in Treatment-Naïve/Treatment-Experienced (TN/TE) French Participants With Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection (MK-5172-
ClinicalTrials.gov study NCT03111108. IPD Sharing: YES. Countries: 1. Publications: 1.
Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy
ClinicalTrials.gov study NCT02060058. IPD Sharing: UNDECIDED. Countries: 1. Publications: 16.
Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype
ClinicalTrials.gov study NCT00894166. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION)
ClinicalTrials.gov study NCT01604850. IPD Sharing: Not stated. Countries: 4. Publications: 3.
A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1
ClinicalTrials.gov study NCT00790673. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection
ClinicalTrials.gov study NCT02378935. IPD Sharing: YES. Countries: 3. Publications: 1.
Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Chronic Genotype 1 or 3 HCV Infection
ClinicalTrials.gov study NCT02074514. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection
ClinicalTrials.gov study NCT01132313. IPD Sharing: Not stated. Countries: 10. Publications: 5.
1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain
ClinicalTrials.gov study NCT01844700. IPD Sharing: Not stated. Countries: 1. Publications: 80.
A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis
ClinicalTrials.gov study NCT03089944. IPD Sharing: YES. Countries: 19. Publications: 1.
Smokers' Response to Nicotine Dependence Genotyping
ClinicalTrials.gov study NCT01780038. IPD Sharing: NO. Countries: 1. Publications: 42.
Efficacy and Safety of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis
ClinicalTrials.gov study NCT02128542. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Influence of OATP1B1 and CYP2C9 Genotypes on the Pharmacokinetics of Bosentan Before and During Clarithromycin
ClinicalTrials.gov study NCT01425229. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients
ClinicalTrials.gov study NCT01466790. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study in Genotype 2 or 3 Patients With Chronic Hepatitis Virus Infection
ClinicalTrials.gov study NCT01257204. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 4 or 5 HCV Infection
ClinicalTrials.gov study NCT02081079. IPD Sharing: YES. Countries: 1. Publications: 2.
Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults
ClinicalTrials.gov study NCT01667731. IPD Sharing: Not stated. Countries: 2. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.